Human challenge models: tools to accelerate the development of malaria vaccines
- 27 February 2019
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Vaccines
- Vol. 18 (3) , 241-251
Abstract
Malaria challenge models, where healthy human volunteers are intentionally infected with Plasmodium species parasites under controlled conditions, can be undertaken in several well-defined ways. These challenge models enable evaluation of the kinetics of parasite growth and clearance, host-pathogen interactions and the host immune response. They can facilitate discovery of candidate diagnostic biomarkers and novel vaccine targets. As translational tools they can facilitate testing of candidate vaccines and drugs and evaluation of diagnostic tests. Until recently, malaria human challenge models have been limited to only a few Plasmodium falciparum strains and used exclusively in malaria-naïve volunteers in non-endemic regions. Several recent advances include the use of alternate P. falciparum strains and other species of Plasmodia, as well as strains attenuated by chemical, radiation or genetic modification, and the conduct of studies in pre-exposed individuals. Herein, we discuss how this diversification is enabling more thorough vaccine efficacy testing and informing rational vaccine development. The ability to comprehensively evaluate vaccine efficacy in controlled settings will continue to accelerate the translation of candidate malaria vaccines to the clinic, and inform the development and optimisation of potential vaccines that would be effective against multiple strains in geographically and demographically diverse settings.Keywords
Funding Information
- National Health and Medical Research Council (1137285)
This publication has 132 references indexed in Scilit:
- Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunityProceedings of the National Academy of Sciences, 2013
- Comparison of Modeling Methods to Determine Liver-to-blood Inocula and Parasite Multiplication Rates During Controlled Human Malaria InfectionThe Journal of Infectious Diseases, 2013
- NF135.C10: A New Plasmodium falciparum Clone for Controlled Human Malaria InfectionsThe Journal of Infectious Diseases, 2012
- Sterile Protective Immunity to Malaria is Associated with a Panel of Novel P. falciparum AntigensMolecular & Cellular Proteomics, 2011
- Substantially Reduced Pre-patent Parasite Multiplication Rates Are Associated With Naturally Acquired Immunity to Plasmodium falciparumThe Journal of Infectious Diseases, 2011
- A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarrayProceedings of the National Academy of Sciences, 2010
- Profiling humoral immune responses to P. falciparum infection with protein microarraysProteomics, 2008
- A proteomic view of the Plasmodium falciparum life cycleNature, 2002
- Genome sequence of the human malaria parasite Plasmodium falciparumNature, 2002
- High diversity and rapid changeover of expressed var genes during the acute phase of Plasmodium falciparum infections in human volunteersProceedings of the National Academy of Sciences, 2002